Compound ID | 1843
Class: Tuberactinomycin (cyclic peptide often grouped with aminoglycoside)
| Spectrum of activity: | Gram-positive |
| Details of activity: | Stabilises peptidyl-tRNA in the pretranslocation complex, preventing translocation of the ribosome along the mRNA, and thus affecting bacterial protein synthesis. Active against Mycobacterium spp. |
| Description: | Streptomyces natural product. Rarely used as alternative for multidrug resistant tuberculosis in combination; administered intravenously or in aerosol form. |
| Year first mentioned: | 1960 |
| Highest development stage: | Approved by FDA in 1971 |
| Development status: | Withdrawn |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/3000502 |
| Guide to Pharmacology: | capreomycin IB |
| Citations: |
|